Lecanemab
id:
lecanemab-183-5999692
title:
Lecanemab
text:
Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. Lecanemab is an amyloid beta-directed antibody. It is given via intravenous infusion. The most common side effects of lecanemab include headache, infusion-related reactions, and amyloid-related imaging abnormalities, a side effect known to occur with the class of antibodies targeting amyloid. Lecanemab was granted accelerated approval for medical use in the United Stat
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody against amyloid beta
original url:
https://en.wikipedia.org/wiki/Lecanemab
date created:
2018-07-26T10:04:10Z
date modified:
2024-09-07T08:25:11Z
main entity:
{"identifier":"Q56274769","url":"https://www.wikidata.org/entity/Q56274769"}
image:
fields total:
13
integrity:
15